Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
United States
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • AI
  • Health Tech
  • Biotechnology
About
Humboldt is a venture capital fund that invests in innovative, early-stage biotech enterprises, focusing on synthetic biology to revolutionize the production of chemicals, materials, foods, and medicines while addressing critical global challenges.
Min check size
$500K
Max check size
$1M
Fund size
NPS

Investment Thesis

They Focuses on early stage investments in technology and healthcare companies that are positioned for significant growth.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Boasting over a decade of experience in private equity and venture capital, the fund manager has successfully navigated multiple sectors, including technology and healthcare, while predominantly targeting North American markets. With a portfolio encompassing more than 30 investments, they emphasize a data-driven strategy that prioritizes operator-first approaches. The manager has achieved notable exits through strategic partnerships and innovative market positioning. Their focus on early to growth-stage investments underscores a commitment to fostering scalable business models with significant potential.

Humboldt Fund Contacts Information

Primary contact

Team

Sebastian Bernales

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp